OLBA HEALTHCARE HOLDINGS, Inc. (TYO:2689)
Japan · Delayed Price · Currency is JPY 2,035.00
+14.00 (0.69%)
Aug 22, 2025, 3:30 PM JST
OLBA HEALTHCARE HOLDINGS Revenue
In the fiscal year ending June 30, 2025, OLBA HEALTHCARE HOLDINGS had annual revenue of 122.70B JPY with 3.49% growth. OLBA HEALTHCARE HOLDINGS had revenue of 30.22B in the quarter ending June 30, 2025, with 3.63% growth.
Revenue
122.70B
Revenue Growth
+3.49%
P/S Ratio
0.10
Revenue / Employee
90.62M
Employees
1,354
Market Cap
12.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 122.70B | 4.14B | 3.49% |
| Jun 30, 2024 | 118.56B | 8.09B | 7.32% |
| Jun 30, 2023 | 110.47B | 2.51B | 2.33% |
| Jun 30, 2022 | 107.96B | -5.02B | -4.44% |
| Jun 30, 2021 | 112.98B | 5.08B | 4.71% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| HOYA Corporation | 876.09B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |